Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
44.35
+1.26 (2.92%)
At close: Feb 9, 2026, 4:00 PM EST
44.75
+0.40 (0.90%)
After-hours: Feb 9, 2026, 6:41 PM EST
Kiniksa Pharmaceuticals International, (KNSA) Revenue by Segment
History
| Date | Product | License and Collaboration |
|---|---|---|
| Jun 30, 2025 | 529.33M | 20.63M |
| Mar 31, 2025 | 475.93M | 32.37M |
| Dec 31, 2024 | 417.03M | 37.08M |
| Sep 30, 2024 | 365.71M | 46.85M |
| Jun 30, 2024 | 318.30M | 110.32M |
| Mar 31, 2024 | 269.40M | 103.34M |
| Dec 31, 2023 | 233.18M | - |
| Sep 30, 2023 | 201.90M | - |
| Jun 30, 2023 | 170.52M | - |
| Mar 31, 2023 | 142.99M | - |
| Dec 31, 2022 | 122.52M | - |
| Sep 30, 2022 | 101.33M | - |
| Jun 30, 2022 | 80.00M | - |
| Mar 31, 2022 | 60.73M | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.